MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/meg.0000000000003049

Медицинская библиотека · European journal of gastroenterology & hepatology · 2025

Disease burden, diagnosis pathways and treatment patterns in patients with eosinophilic esophagitis: a real-world study.

Ma Christopher, von Arm Ulrike, Zerbib Frank, Pela Tiffany, Radwan Amr, Jacob-Nara Juby A, Parikh Rohan C, Borsos Kinga, Bello Fareedat, Thomas Ryan B, Tilton Sarette T

СтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

BACKGROUND

Despite a rising prevalence of eosinophilic esophagitis (EoE), real-world data on current management challenges remain limited.

OBJECTIVE

To evaluate demographic and clinical characteristics, treatment patterns, and health outcomes in patients with EoE.

METHODS

Physicians from Canada, France, Germany, Spain, and the UK retrospectively reviewed records of patients (aged ≥12 years) who were newly diagnosed with EoE between January 2009 and December 2019. EoE diagnosis was confirmed by esophageal biopsy demonstrating a peak eosinophil count ≥15 eosinophils/high-power field (eos/hpf) within 90 days before or after the documented diagnosis (index). Included patients had ≥1 follow-up endoscopy with biopsy and known eosinophil count within 24 months. Data on demographics, clinical characteristics, treatment, and health outcomes were collected 12-month preindex to the last record entry/death.

RESULTS

Overall, 415 patients [mean age (SD): 31.8 (14.6) years] were included. The mean (SD) diagnostic delay from symptom onset was 3.4 (4.8) years [median (range): 1.7 (0.7-4.0)]. The average eosinophil count was 41.4 eos/hpf; 80.2% of patients had endoscopic abnormalities of the esophagus at diagnosis. Post-EoE diagnosis, 77.1% of patients received proton-pump inhibitors, 68.2% swallowed topical corticosteroids, 48.4% made dietary modifications, and 18.8% had esophageal dilation. At diagnosis, 74.5% of patients had dysphagia and 46.0% had heartburn. After diagnosis, 63.5%, 62.2%, and 57.6% did not achieve histologic remission (<15 eos/hpf) at the first, second, and third endoscopy, respectively.

CONCLUSION

Patients with EoE experience a substantial disease burden, with a significant delay in diagnosis. Achieving optimal disease control remains an unmet need with conventional nonbiologic therapies.

Для цитирования: Ma Christopher, von Arm Ulrike, Zerbib Frank, Pela Tiffany, Radwan Amr, Jacob-Nara Juby A, Parikh Rohan C, Borsos Kinga, Bello Fareedat, Thomas Ryan B, Tilton Sarette T. Disease burden, diagnosis pathways and treatment patterns in patients with eosinophilic esophagitis: a real-world study.. European journal of gastroenterology & hepatology. 2025. DOI: 10.1097/meg.0000000000003049.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.